It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a company ...

Industry Insight from Reuters Events, a part of Thomson Reuters. A new factory shows how sodium ion will gain an increasing share of the U.S. energy storage market as developers seek to reduce ...

Figure 1. Schematic representation of current uses of calcium carbonate discussed in this mini review. Figure 4. Global average surface temperature increase from 1901 to 2000 average based on data ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

Scientists at the US Department of Energy’s Argonne National Laboratory have achieved an important advancement in making sodium-ion batteries more effective. They have developed a new way to ...

Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years. Merck should have the means to get around these headwinds ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

Lithium-ion batteries have long dominated the market as the go-to power source for electric vehicles. They are also increasingly being considered for storage of renewable energy to be used on the ...

The agreement grants Merck the option to license Evaxion’s preclinical vaccine candidates EVX-B2 and EVX-B3. Evaxion also granted Merck an option to license preclinical vaccine candidates EVX-B2 ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

Merck (MRK) closed the latest trading day at $113.09, indicating a -1.43% change from the previous session's end. This change lagged the S&P 500's daily gain of 0.4%. Elsewhere, the Dow gained 0. ...

Daily sodium intake above 2,300 milligrams (mg) is a cardiovascular (heart) disease risk factor. While some sodium is needed for the body to function properly, too much can raise the risk of high ...